Involved/uninvolved immunoglobulin ratio identifies monoclonal gammopathy of undetermined significance patients at high risk of progression to multiple myeloma
- 22 November 2013
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 164 (5) , 752-755
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathyClinical Biochemistry, 2012
- Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUSLeukemia, 2012
- Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myelomaExperimental Hematology & Oncology, 2012
- Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myelomaLeukemia, 2011
- Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cellsBritish Journal of Haematology, 2009
- Pathogenesis and progression of monoclonal gammopathy of undetermined significanceLeukemia, 2008
- Monoclonal Gammopathy of Undetermined Significance: Predictors of Malignant Transformation and Recognition of an Evolving Type Characterized by a Progressive Increase in M Protein SizeMayo Clinic Proceedings, 2007
- Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined SignificanceJournal of Clinical Oncology, 2005
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005